Eight weeks of Paritaprevir/r/Ombitasvir + Dasabuvir in HCV genotype 1b with mild-moderate fibrosis: Results from a real-world cohort.
Marc PuigvehíBeatriz De CuencaAna ViuMoisés DiagoJuan TurnesFrancisco GeaJuan M PascasioSabela LensJoaquín CabezasEster BadiaAntonio OlveiraRosa M MorillasXavier TorrasSilvia MontoliuPatricia CorderoJosé L CastroJavier SalmerónEsther MolinaJuan J Sánchez-RuanoJavier MorenoMaría D AntónJosé M MorenoJuan De la VegaJosé L CallejaJose Antonio CarriónPublished in: Liver international : official journal of the International Association for the Study of the Liver (2018)
Treatment with PTV/r/OBV/DSV in genotype 1b-infected treatment-naive patients with mild-moderate fibrosis shows excellent efficacy and safety in real life, similarly to clinical trials. Clinicaltrials.gov, number: NCT03122132.